1.Complexity of Langerin+DC network revisited  in J. Exp. Med 2007,

Gignhoux F.et al., Poulin L. et al., Bursch LS. et al.,

2.Spotlight on basophils in  Nature Immunol, March 2008,Vol.9, Immunity, April, n°28, Nature Reviews Immunology, July 2008, vol.8,

Sokol C et al., Min B. et al, 2008, Nature Immunol; Galli S et al., 2008, Immunity 28;Tsujimura Y. et al, 2008,Immunity 28;

Basophils and immunological memory: Allan A., 2008, Nature Reviews Immunol, 8; Kawakami T., 2008, Nature Immunol,9; Denzel A. et al., 2008, Nature Immunol, 9.

3.Early endocytic compartment, DCs  and  antigen cross presentation: Nature Immunol, 2008, vol.9: Di Pucchio T. et al., 551-; Burgdorf S. et al., 558-.

4.DENDRITICS antibodies for Langerin molecule organization study. Monoclonal antibodies anti-Langerin recognize different constructs of Langerin molecule (Valladeau J. et al., 2002, J Immunol.,168, 782-; Kissenpfennig A. et al., 2005 Molecular Immunol., 25, 88-)

5.Spotlight on DCIR (Dendritic Cell Immuno Receptor):

DCIR & pDCs: Meyer-Wentrup F. et al., 2008 Blood, vol 111

DCIR, DCs & HIV: Lambert A.A. et al., 2008 Blood ,vol 112,

 6.Spotlight on DC-LAMP antibody clone 1010E1 (DDX0191)

Dieu-Nosjean MC et al., 2008 Journal of Clinical Oncology, 26, 4410 show a relation between the number of tumor-infiltrating mature DCs and NSCLC prognosis. Anti-DC-LAMP clone 1010E1  was utilized to detect mature DCs.

See also Coppola D et al., 2008 JCO, 26,4369

7.DC biology- Immunity, 2008, 29, issue 3

Belkaid Y., et al.Tuning microenvironments:induction of regulatory T cells by dendritic cells; Lopez-Bravo M., et al.In vivo induction of immune responses to pathogens by conventional dendritic cells;Alvarez D. et al.,Mechanisms and consequences of dendritic cell migration;Villadangos JA., et al.,; Melief CJM.Cancer immunotherapy by dendritic cells;Steinmann RM.Dendritic cells in vivo:a key target for a new vaccine science.